← All indications
Oxidative Stress
A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).
Subtype terms (3)
More specific conditions that are subtypes of Oxidative Stress in the MeSH hierarchy.
Drugs by status
Phase 4 trials (30)
- melatonin
- propofol
- vitamin e
- acetylcysteine
- cisatracurium
- alpha-lipoic acid
- ferric carboxymaltose
- sevoflurane
- insulin human
- idebenone
- etomidate
- krill oil
- pitavastatin
- penehyclidine
- atorvastatin
- ferumoxytol
- vildagliptin
- aronia extract
- chokeberry extract
- cyclodextrin
- dexmedetomidine
- fentanyl
- midazolam
- pioglitazone
- oxygen
- sodium chloride
- remifentanil
- omega-3 fatty acids
- selenium
- anthocyanins
Phase 3 trials (25)
Phase 2 trials (27)
- simvastatin
- ezetimibe
- amitriptyline
- oxytocin
- astaxanthin
- candesartan
- enalapril
- rosuvastatin
- nitrogen
- magnesium oxide
- whey protein
- nitric oxide
- lactose
- acetaminophen
- hyaluronic acid
- sitagliptin
- secoisolariciresinol
- cellulose
- nicotinamide
- zeaxanthin
- hydroxycitrate
- perindopril
- zinc oxide
- lutein
- ubiquinone
- Silibinin
- copper sulfate
Phase 1 trials (22)
Other trials (97)
- nitrous oxide
- maltodextrin
- s-methionine
- sucrose
- bacopa monnieri
- beetroot juice
- beta carotene
- black raspberry
- brussel sprouts
- l-carnosine
- cocoa bean
- cranberry
- dark chocolate
- prednisone
- ibuprofen
- essential oils
- isoflurane
- ginger
- hydrogen
- hydroxytyrosol
- ozone
- deferiprone
- kefir
- levocarnitine
- lithium
- cow milk
- febuxostat
- ropivacaine
- plantago ovata
- praziquantel
- +67 more